• Mayo Clinic, OmniTier speed up de novo genome sequencing fiercebiotech
    August 16, 2018
    In a joint study, Mayo Clinic and OmniTier have shown that de novo genome sequencing—which does not use a reference genome—can be used in whole genome sequencing without the need for “supercomputing-level resources,” making the speedier sequencing process
PharmaSources Customer Service